Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Clinical trial NCT00924170 · COMPLETED
Trial details
- NCT number
- NCT00924170
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-31
- Primary completion
- 2016-01-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.